Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Trials|March 28, 2007
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trialEusebio V Macete, Jahit Sacarlal, John J Aponte, et al.
The Journal of Infectious Diseases|July 3, 2009
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protectionKent E Kester, James F Cummings, Opokua Ofori-Anyinam, et al.
Lancet (London, England)|October 24, 2007
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trialJohn J Aponte, Pedro Aide, Montse Renom, et al.
Plos One|March 11, 2017
Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccineMatthew B Laurens, Bourema Kouriba, Elke Bergmann-Leitner, et al.
Vaccine|June 19, 2007
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adultsKent E Kester, Denise A McKinney, Nadia Tornieporth, et al.
Vaccine|April 5, 2008
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of ResearchKent E Kester, James F Cummings, Christian F Ockenhouse, et al.
Frontiers in Immunology|May 16, 2020
The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria InfectionYing Du, Ethan G Thompson, Julius Muller, et al.
The New England Journal of Medicine|December 10, 2008
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infantsSalim Abdulla, Rolf Oberholzer, Omar Juma, et al.
Plos One|August 4, 2009
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission areaMark E Polhemus, Shon A Remich, Bernhards R Ogutu, et al.
Lancet (London, England)|October 19, 2004
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trialPedro L Alonso, Jahit Sacarlal, John J Aponte, et al.
Pageof 8